A comprehensive view of Cancer. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bayer opens new US$140M, 62,100 square-foot molecular oncology research, innovation center in Boston, Massachusetts, focused on developing targeted cancer therapies; center to enhance collaboration between Bayer, internal partners

McKesson and HCA Healthcare form JV combining McKesson’s US Oncology Research, HCA’s Sarah Cannon Research Institute to expand research, drug development, availability to clinical trials; McKesson also acquires Genospace personal medicine platform

Eli Lilly partners with digital therapeutics firm Sidekick Health to launch integrated digital therapeutics solution in Germany to provide tailored treatment plan for breast cancer patients; other international markets for solution under consideration

Global gynecological cancer drug market projected to hit US$21.8B by 2030, with CAGR growth of 6.5% from 2021 to 2030; growth driven by increase in gynecological cancers, increased investment in cancer treatments; increased early screening

FDA grants Breakthrough Therapy Designation for Janssen’s talquetamab injectable antibody to treat relapsed or refractory multiple myeloma, a cancer of plasma cells; multiple myeloma affects 34,000 people in US annually, 176,000 worldwide

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count